Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mediolanum Farmaceutici SRL

www.mediolanum-farma.it/en

Latest From Mediolanum Farmaceutici SRL

Deals Shaping the Medical Industry, December 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2016.

Deals BioPharmaceutical

DEALS ROUND-UP: M&A and partnering 1-28 December

As companies flurried to clinch deals by the end of the year, a number of significant agreements were signed or completed last December.

Metabolic Disorders Infectious Diseases

Deals Of The Week: Baxter/Gambro, Optimer/AstraZeneca, Ironwood/Protagonist

Three rapid-fire clinical setbacks scuttled a planned merger between BioCryst and Presidio that would have created a new competitor in the hepatitis C space. Now, BioCryst is retrenching with a staff cut and narrower R&D focus.

BioPharmaceutical Deals

Mediolanum Acquires Phase II-Ready Cancer Vaccine From Italy’s Genovax

Italian life sciences seed capital firm Eporgen Venture has used a network of wealthy individuals in Italy to fund a group of new biotech companies, and has entered into its first transaction, selling Genovax’s potential cancer vaccine to Italian pharmaceutical company Mediolanum.

BioPharmaceutical Italy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Parent & Subsidiaries
  • Mediolanum Farmaceutici SRL
  • Senior Management
  • Romano Deghenghi, Pres. & CEO, Europeptides
    Francesco Fazio, Dir., Fin. & Admin.
    Luigi Galeazzi, Dir., Licensing
    Luca Piovella, Dir., Mktg.
    Paolo Lucchelli, VP, Scientific Affairs
  • Contact Info
  • Mediolanum Farmaceutici SRL
    Phone: (33) 0289132.1
    Via S. Giuseppe Cottolengo, 15
    Milan, 20143
    Italy
UsernamePublicRestriction

Register